Your Notifications
All done, no notifications

Pediatric Cardiomyopathy Treatment Cost in Istanbul

Starts from USD 13500

Disclaimer: Cost range is subject to change based on clinical evaluation.

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

2
Days in Hospital
2-6 hrs
Procedure Time
80-90%
Success Rate
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
Starts from USD 13500
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator

International Quality. Affordable Care.
The Cost of Pediatric Cardiomyopathy Treatment in Istanbul is available starts from USD 13500.

Cost of Pediatric Cardiomyopathy Treatment in Major Cities of Turkey

CityCost (USD)
Ankara Starting $13k Explore More
Antalya Starting $13k Explore More
Bursa Starting $13k Explore More
Fethiye Starting $13k Explore More
Istanbul Starting $13.5k Explore More
Kocaeli Starting $15k Explore More
Konya Starting $13k Explore More
Ordu Starting $13k Explore More
Samsun Starting $13k Explore More
Tokat Starting $13k Explore More
Trabzon Starting $13k Explore More
Dr. Shagufta Parveen
Author

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

View More
Dr. Naresh Kumar Goyal
Reviewer

Cardiologist

21 Years of Experience

Last Reviewed - June 2026

Dr. Naresh Kumar Goyal is highly trained as a cardiologist with exposure in virtually all aspects of cardiology. He qualified with an MD in internal medicine in 1999 from SMS Medical College, Jaipur, and served in the Cardiology Department as an honorary resident. From this stage, he also started with training in the temporary pacing of the pacemaker as well as interventional services.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

15 min
Average response time

Serving Patients Worldwide in Multiple Languages.

Pediatric cardiomyopathy is a condition where the heart muscle becomes weak or stiff. This reduces the blood supply to heart and body leading to heart failure in infants or children. Other complications include irregular rhythms or even sudden death of infants. The primary types of pediatric cardiomyopathy include:

  • Dilated Cardiomyopathy (DCM): The condition is characterized by thinning and enlargement of heart chambers leading to poor blood flow. It is the most common type of cardiomyopathy.
  • Hypertrophic Cardiomyopathy (HCM): The condition is characterized by thickening of heart muscle leading to poor blood flow. Symptoms like breathlessness, palpitations and fatigue are common.
  • Restrictive Cardiomyopathy (RCM): The heart muscle becomes stiff or rigid characterised by decreased blood flow.
  • Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): The right ventricle of the heart is affected, leading to irregular rhythms and sudden cardiac disorders.

Treatment for pediatric cardiomyopathy is required when a child is identified with a cardiac muscle condition that impairs the heart's capacity to pump blood efficiently. The three most prevalent kinds are restricted, hypertrophic, and dilated cardiomyopathy. The goals of treatment are to control symptoms, enhance cardiac function, and avoid side effects such as arrhythmias or heart failure.

A pediatric cardiologist should be seen if a child exhibits symptoms including chest pain, irregular heartbeats, exhaustion, fainting, poor feeding, or trouble breathing. Early identification is essential, particularly if there is a family history of cardiomyopathy or sudden cardiac death. Routine imaging and follow-ups determine the right treatment strategy and intervention timing.

A thorough cardiac assessment, which includes an echocardiography, electrocardiogram, chest X-ray, blood tests, and occasionally genetic testing or cardiac MRI, is the first step in the evaluation process. Reviewing medications is crucial to preventing interactions. Fasting and preoperative testing are necessary if surgical treatment or device placement is being considered. Depending on the child's age and condition, the care staff will give detailed instructions.

  • Medications: Used to treat symptoms and enhance cardiac performance.
  • Device Therapy: Device therapy may involve the implantation of pacemakers, ICDs, or VADs, if necessary.
  • Surgery/Transplant: In extreme, non-responsive instances, a heart transplant may be considered.
  • Monitoring: It's important to have routine examinations, imaging, and lifestyle modifications.

Treatment is ongoing and depends on the severity and progression of the disease. Medication adjustments, follow-ups, and lifestyle adaptations are part of lifelong management. If surgery or transplant is needed, hospitalisation may last from several days to weeks, followed by extended recovery.

  • Heart failure
  • Life-threatening arrhythmias
  • Stroke or blood clots
  • Device-related complications
  • Side effects from long-term medications

Early and adequate treatment can relieve symptoms, improve cardiac function, and increase survival. It also improves the child's quality of life by enabling them to play, grow, and go to school. The disease's course can frequently be halted or reduced.

Rehabilitation, medication management, and hospital monitoring are all part of the healing process for kids after surgery or device placement. Regular cardiologist visits, imaging, and family education regarding symptom awareness and lifestyle measures are all part of ongoing care.

Success depends on the type and stage of cardiomyopathy. Medical and technological therapy are effective for many kids. Improvements in early intervention and pediatric cardiac care continue to increase survival and quality of life.

80-90%

Long-term symptom control and improved quality of life with appropriate treatment

2-7 days

Typical hospital stay for medical management or interventional procedures

1-2Months

Regular follow-up with pediatric cardiology for monitoring heart function and disease progression
Explore Hospitals ( 25 )

Istanbul, Turkey

4.6 - 1125 reviews · 112+ Beds · 233+ Procedures
JCI
Starting
USD 15000
Chat with a Medical Advisor

Istanbul, Turkey

3.7 - 1903 reviews · 441+ Beds · 296+ Procedures
JCI
Starting
USD 13500
Chat with a Medical Advisor

Istanbul, Turkey

3.8 - 1289 reviews · 804+ Beds · 209+ Procedures
JCI
Starting
USD 15000
Chat with a Medical Advisor

Istanbul, Turkey

3.9 - 3397 reviews · 197+ Beds · 171+ Procedures
ISO JCI
Starting
USD 13500
Chat with a Medical Advisor

Istanbul, Turkey

4.3 - 2386 reviews · 154+ Beds · 253+ Procedures
JCI
Starting
USD 15000
Chat with a Medical Advisor

Istanbul, Turkey

3.5 - 2536 reviews · 186+ Beds · 237+ Procedures
JCI
Starting
USD 13500
Chat with a Medical Advisor

Istanbul, Turkey

4.3 - 1593 reviews · 100+ Beds · 120+ Procedures
JCI
Starting
USD 13500
Chat with a Medical Advisor

Istanbul, Turkey

4.4 - 3369 reviews · 350+ Beds · 221+ Procedures
JCI ISO
Starting
USD 15000
Chat with a Medical Advisor

Istanbul, Turkey

4.2 - 3199 reviews · 278+ Beds · 237+ Procedures
JCI
Starting
USD 15000
Chat with a Medical Advisor

Istanbul, Turkey

4.0 - 4907 reviews · 394+ Beds · 197+ Procedures
ISO JCI
Starting
USD 15000
Chat with a Medical Advisor

Get Your Pediatric Cardiomyopathy Treatment
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Mr Hailu Kassa : CABG Surgery
Mr Hailu Kassa
Mr Hailu Kassa : CABG Surgery

Mr. Hailu Kassa underwent Coronary Artery Bypass Surgery in Vejthani Hospital, Thailand under the supervision of Dr. Piya, Cardio-Thoracic Surgeon

Rod Schaubroeck
Rod Schaubroeck
Rod Schaubroeck : Double Valve Replacement

Patient Testimonial: Rod Schaubroeck from United States (U.S.A) underwent heart valve replacement at Fortis Hospital, India

Frequently Asked Questions

The cost of pediatric cardiomyopathy treatment in Istanbul may vary depending on the type and severity of cardiomyopathy, the child's age, diagnostic investigations, treatment approach, hospital charges, paediatric cardiologist's fees, medications, and length of hospital stay. The overall cost may include specialist consultations, ECG, echocardiography, cardiac imaging, genetic testing where indicated, catheter-based procedures or surgery, medications, intensive care, and follow-up care.MediGence can help international patients explore suitable paediatric cardiac centres and obtain an estimated treatment plan based on the child's cardiac condition, treatment requirements, and overall clinical status.

The best hospitals in Istanbul for pediatric cardiomyopathy treatment are those with experienced paediatric cardiologists, paediatric cardiac surgeons, electrophysiologists, heart failure specialists, cardiac intensivists, genetic specialists, and multidisciplinary paediatric cardiac teams. Patients should consider hospitals with specialised paediatric cardiac units, advanced cardiac imaging, catheterisation laboratories, paediatric intensive care facilities, and comprehensive heart failure programmes.Hospitals with experience in managing complex cardiomyopathies and advanced paediatric heart failure may be particularly suitable for children requiring specialised cardiac care.

Patients should choose a paediatric cardiologist or paediatric heart failure specialist experienced in diagnosing and managing cardiomyopathy in children. Important factors include expertise in heart failure management, cardiac imaging, rhythm disorders, genetic cardiomyopathies, medication optimisation, catheter-based procedures, and advanced therapies where required.The treating team should assess the type of cardiomyopathy, heart function, symptoms, ECG findings, echocardiography, cardiac imaging, family history, genetic factors, associated conditions, and overall health before recommending a treatment plan.

The success of pediatric cardiomyopathy treatment in Istanbul varies depending on the type and severity of cardiomyopathy, the child's age, underlying cause, degree of heart dysfunction, treatment approach, associated conditions, and overall clinical status. Outcomes are generally influenced by early diagnosis, appropriate treatment, experienced paediatric cardiac teams, and close long-term monitoring.Treatment outcomes may be assessed through improvement in heart function, symptom control, exercise tolerance, growth and development, reduction in hospitalisations, and long-term cardiac stability. The treating paediatric cardiology team can provide a more individualised prognosis after evaluating the child's condition.

Hospitals in Istanbul may use ECG, Holter monitoring, echocardiography, cardiac MRI, cardiac CT where indicated, exercise testing, genetic testing, cardiac catheterisation, advanced haemodynamic monitoring, and specialised paediatric intensive care facilities.Treatment depends on the type and severity of cardiomyopathy and may involve medication, rhythm management, catheter-based procedures, device therapy, surgical intervention, mechanical circulatory support, or heart transplantation for selected children with advanced heart failure. Nutritional support and cardiac rehabilitation may also form part of the treatment plan.

Possible risks and complications may include:
  • Abnormal heart rhythms
  • Worsening heart failure
  • Low blood pressure
  • Blood clots
  • Infection
  • Medication-related side effects
  • Kidney or liver dysfunction
  • Catheter-related complications
  • Device-related complications where applicable
  • Surgical complications
  • Need for intensive care
  • Need for mechanical circulatory support or transplantation in severe cases
  • The specific risks depend on the type of cardiomyopathy, treatment approach, child's age, associated conditions, and overall health. The treating paediatric cardiac team will explain the potential risks and expected benefits before treatment.

    Patients should share all relevant medical records with the treating paediatric cardiology team before travelling. These may include ECGs, echocardiography reports, Holter monitoring records, cardiac MRI or CT findings, catheterisation reports, genetic testing results, blood test results, previous hospitalisation records, medication history, and allergy information.Parents or caregivers should also discuss the planned treatment, expected hospital stay, medication adjustments, possible intensive care requirements, activity restrictions, nutritional needs, follow-up schedule, and travel arrangements before making their plans.

    Yes. International patients can arrange an online consultation with a paediatric cardiologist, paediatric heart failure specialist, or paediatric cardiac surgeon before travelling to Istanbul. The specialist may review the child's ECG, imaging studies, symptoms, medical history, family history, previous treatment, and overall clinical condition to determine the appropriate treatment approach.MediGence can help coordinate online consultations and facilitate the secure sharing of relevant medical records and cardiac investigations with suitable paediatric cardiac specialists.

    International patients should carry a valid passport and relevant medical documents, including:
  • ECG and Holter monitoring reports
  • Echocardiography reports
  • Cardiac MRI or CT reports, if applicable
  • Cardiac catheterisation reports, if applicable
  • Genetic testing reports, if available
  • Recent blood test results
  • Previous paediatric cardiology consultation records
  • Previous hospitalisation and treatment records
  • Current prescriptions and medication details
  • Allergy and complete medical history
  • Parents or caregivers should also carry digital copies of important medical records and imaging for easy access during consultations and treatment.

    The required stay in Istanbul depends on the child's cardiac condition, treatment approach, response to therapy, complications, and need for rehabilitation or further procedures. Children undergoing advanced treatment may require hospitalisation for close cardiac monitoring, particularly when there is significant heart failure or an abnormal heart rhythm.International patients may need to remain in Istanbul for additional follow-up after discharge to assess heart function, adjust medications, monitor symptoms, and confirm clinical stability. Children requiring procedures, mechanical circulatory support, or transplantation may need a longer stay.

    Recovery after pediatric cardiomyopathy treatment varies depending on the type of cardiomyopathy, severity of heart dysfunction, treatment approach, child's age, and overall health. Children receiving medical therapy may gradually resume age-appropriate activities according to their cardiologist's recommendations.Children undergoing catheter-based procedures or surgery may require additional recovery and rehabilitation. Long-term follow-up may include regular ECGs, echocardiography, Holter monitoring, cardiac imaging, medication adjustment, assessment of growth and development, and ongoing heart failure management.

    If complications occur, parents or caregivers should contact the treating paediatric cardiac team or seek immediate medical attention. Prompt evaluation may be required for severe breathing difficulty, chest pain, fainting, persistent palpitations, unusual fatigue, swelling, bluish skin or lips, reduced activity, or other symptoms suggesting worsening heart function or an abnormal heart rhythm.Families should receive detailed discharge instructions, medication guidance, activity recommendations, warning signs, emergency contact information, and a structured cardiac follow-up plan before returning home.

    International patients can submit the child's medical records, cardiac reports, imaging studies, and previous treatment details through the MediGence website. Following an initial review, the MediGence care team can help families explore suitable paediatric cardiac hospitals and experienced specialists, coordinate consultations, and support treatment planning and medical travel arrangements.The final treatment recommendation is made by the treating paediatric cardiac team after a comprehensive evaluation of the child's diagnosis, cardiac function, and clinical requirements.

    International patients may choose Istanbul for access to experienced paediatric cardiologists, specialised paediatric heart failure programmes, advanced cardiac imaging, modern catheter-based and surgical facilities, paediatric intensive care, and multidisciplinary cardiac care.The destination should be evaluated based on hospital accreditation, patient safety standards, paediatric cardiac expertise, experience in managing cardiomyopathy, availability of advanced cardiac technologies, and access to long-term follow-up and rehabilitation services.

    Treatment options depend on the type and severity of cardiomyopathy, child's age, heart function, symptoms, underlying cause, and overall health. Options may include:
  • Heart failure medications
  • Medicines for controlling abnormal heart rhythms
  • Anticoagulation where indicated
  • Nutritional and supportive therapy
  • Cardiac rehabilitation and activity management
  • Catheter-based procedures
  • Pacemaker or implantable cardioverter-defibrillator in selected children
  • Mechanical circulatory support for severe heart failure
  • Ventricular assist devices in selected cases
  • Heart transplantation for advanced or refractory heart failure
  • Long-term paediatric cardiology follow-up
  • The treating multidisciplinary paediatric cardiac team will recommend the most appropriate treatment plan after evaluating the child's cardiomyopathy, heart function, symptoms, underlying cause, and overall clinical condition.

    International patients may choose Istanbul for access to specialised paediatric cardiac centres, experienced paediatric cardiologists and cardiac surgeons, advanced diagnostic technologies, modern catheterisation and surgical facilities, paediatric intensive care, and structured long-term cardiac follow-up.MediGence can assist families with hospital and specialist selection, medical record coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the child's type and severity of cardiomyopathy, clinical requirements, treatment goals, and the hospital's expertise in paediatric cardiomyopathy management.

    Not Sure About Your Treatment Plan? Get a Second Opinion

    Get your medical reports reviewed by experienced doctors to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan